BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 251 filers reported holding BLUEBIRD BIO INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $564,000 | +15.6% | 17,637 | +95.0% | 0.05% | +54.8% |
| Q3 2020 | $488,000 | -69.5% | 9,046 | -65.5% | 0.03% | -72.1% |
| Q2 2020 | $1,599,000 | +18.9% | 26,194 | -10.5% | 0.11% | +13.3% |
| Q1 2020 | $1,345,000 | -5.3% | 29,254 | +266.9% | 0.10% | -37.2% |
| Q4 2017 | $1,420,000 | +383.0% | 7,973 | +184.8% | 0.16% | +95.0% |
| Q2 2017 | $294,000 | -67.1% | 2,800 | -86.7% | 0.08% | -23.8% |
| Q1 2016 | $893,000 | -44.7% | 21,000 | +118.8% | 0.10% | -42.0% |
| Q2 2015 | $1,615,000 | +199.6% | 9,600 | +115.0% | 0.18% | +229.1% |
| Q1 2015 | $539,000 | – | 4,465 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |